Market Research Logo

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

“eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022”

The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.

On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region.

Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2016. Partnerships, agreements, and collaborations; product launches, enhancements, and deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most players to achieve growth in the eClinical solutions market.

Research Coverage:
The report covers software solutions used across all phases in the clinical trial process. It aims at estimating the market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions. The report also includes an in-depth competitive analysis of the key players with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:
This report focuses on various levels of analysis—market share analysis of the top players and company profiles, which discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner greater market shares. Companies purchasing the report could use any one of the combination of the strategies mentioned below, namely, market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the market. The report analyzes the eClinical solutions market, by product, delivery mode, clinical trial phase, and end users across four geographies.

• Product Development/Innovation: Detailed insights on current technologies, research and development activities, and product launches in the eClinical solutions market.

• Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).

• Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • MAJOR MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ECLINICAL SOLUTIONS: MARKET OVERVIEW
    • ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 VS. 2015 VS. 2022 (USD MILLION)
    • REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016)
    • ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017 VS. 2022)
    • REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017–2022)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MAJOR MARKET DRIVERS
        • Table U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015
      • MAJOR MARKET RESTRAINTS
      • KEY GROWTH OPPORTUNITIES
      • MAJOR MARKET CHALLENGES
  • GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
    • ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
      • Table GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • CLINICAL TRIAL MANAGEMENT SYSTEMS
      • Table GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • CLINICAL ANALYTICS PLATFORMS
      • Table GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
      • Table GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • CLINICAL DATA INTEGRATION PLATFORMS
      • Table GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
      • Table GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • SAFETY SOLUTIONS
      • Table GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • ELECTRONIC TRIAL MASTER FILE SYSTEMS
      • Table GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
    • REGULATORY INFORMATION MANAGEMENT SOLUTIONS
      • Table GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER ECLINICAL SOLUTIONS
      • Table GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
  • ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
    • INTRODUCTION
      • Table GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015–2022 (USD MILLION)
    • WEB-HOSTED (ON-DEMAND) SOLUTIONS
      • Table WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
    • LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS
      • Table LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
    • CLOUD-BASED (SAAS) SOLUTIONS
      • Table CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
  • GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
    • INTRODUCTION
      • Table GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION)
    • PHASE I CLINICAL TRIALS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION)
    • PHASE II CLINICAL TRIALS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION)
    • PHASE III CLINICAL TRIALS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION)
    • PHASE IV CLINICAL TRIALS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION)
  • ECLINICAL SOLUTIONS MARKET, BY END USER
    • INTRODUCTION
      • Table GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
    • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015)
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015–2022 (USD MILLION)
    • CONSULTING SERVICE COMPANIES
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015–2022 (USD MILLION)
    • MEDICAL DEVICE MANUFACTURERS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015–2022 (USD MILLION)
    • HOSPITALS
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015–2022 (USD MILLION)
    • ACADEMIC RESEARCH INSTITUTES
      • Table ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
  • ECLINICAL SOLUTIONS MARKET, BY REGION
    • INTRODUCTION
      • Table GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
      • U.S.
        • Table U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
        • Table U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
      • CANADA
        • Table CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
        • Table CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
    • EUROPE
      • Table EMA-APPROVED BIOSIMILARS
      • Table EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
      • Table EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2022 (USD MILLION)
      • Table EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION)
      • Table EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
      • Table ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2022 (USD MILLION)
      • Table ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION)
      • Table ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
      • Table ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2022 (USD MILLION)
      • Table ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION)
      • Table ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013–2017)
      • PRODUCT DEPLOYMENTS
        • Table PRODUCT DEPLOYMENTS (2013–2017)
      • PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS
        • Table PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013–2017)
      • MERGERS & ACQUISITIONS
        • Table MERGERS & ACQUISITIONS (2013–2017)
      • EXPANSIONS
        • Table EXPANSIONS (2013–2017)
      • OTHER STRATEGIES
        • Table OTHER STRATEGIES (2013–2017)
  • COMPANY PROFILES
    • INTRODUCTION
      • GEOGRAPHIC BENCHMARKING
    • ORACLE CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
      • MNM VIEW
    • MEDIDATA SOLUTIONS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
      • MNM VIEW
    • PAREXEL INTERNATIONAL CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
      • MNM VIEW
    • BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
      • MNM VIEW
    • DATATRAK INTERNATIONAL, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • CRF HEALTH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • ERT CLINICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • MERGE HEALTHCARE INCORPORATED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • OMNICOMM SYSTEMS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • MAXISIT INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • BIO-OPTRONICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
    • ECLINICAL SOLUTIONS, LLC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2017)
  • APPENDIX
    • DISCUSSION GUIDE*
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report